Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Next Deadline
30 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
August 27, 2025
Extension Available
Until February 27, 2025
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 27, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 27, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 27, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 29, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 29, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 29, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 29, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 27, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 2, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 2, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 13, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 27, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 26, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 25, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 25, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 26, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 26, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 26, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 19, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 6, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 25, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials and conveying the information to patients, medical professionals, and the public; Providing information on the subject of scientific research in the field of biochemistry and biotechnology
Class 044
Providing medical information and treatment information in the field of pharmaceuticals, immunology, hematology, cardiovascular and metabolic conditions, respiratory conditions, transplant therapeutic areas, plasma, blood plasma, vaccines, iron deficiency, anaemia, heart failure, kidney disease, gastroenterology conditions, inflammatory bowel disease, and blood conditions; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and conveying the information to patients, medical professionals, and the public
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECHNOLOGY"